Media coverage about Tenet Healthcare (NYSE:THC) has trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Tenet Healthcare earned a media sentiment score of 0.08 on Accern’s scale. Accern also assigned news stories about the company an impact score of 46.4200134838773 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
These are some of the news stories that may have effected Accern’s scoring:
THC has been the topic of a number of research reports. Wells Fargo & Co initiated coverage on shares of Tenet Healthcare in a report on Tuesday, January 30th. They set a “market perform” rating and a $20.00 target price on the stock. Citigroup upped their price target on shares of Tenet Healthcare from $19.00 to $27.00 and gave the stock a “buy” rating in a research note on Thursday, March 1st. ValuEngine cut shares of Tenet Healthcare from a “buy” rating to a “hold” rating in a research note on Monday, April 2nd. Morgan Stanley upped their price target on shares of Tenet Healthcare from $15.00 to $16.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 28th. Finally, SunTrust Banks reiterated a “hold” rating and issued a $27.00 price target on shares of Tenet Healthcare in a research note on Tuesday, April 17th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and eight have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $25.63.
Shares of Tenet Healthcare stock opened at $33.70 on Friday. The stock has a market capitalization of $3.38 billion, a P/E ratio of 41.60, a PEG ratio of 1.65 and a beta of 0.81. Tenet Healthcare has a 1 year low of $12.25 and a 1 year high of $34.16. The company has a current ratio of 1.24, a quick ratio of 1.17 and a debt-to-equity ratio of 23.09.
Tenet Healthcare (NYSE:THC) last issued its earnings results on Monday, April 30th. The company reported $0.57 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.04) by $0.61. Tenet Healthcare had a positive return on equity of 23.13% and a negative net margin of 2.90%. The business had revenue of $4.70 billion during the quarter, compared to analyst estimates of $4.56 billion. During the same quarter in the previous year, the firm earned ($0.27) EPS. Tenet Healthcare’s revenue was down 2.4% on a year-over-year basis. analysts expect that Tenet Healthcare will post 1.54 earnings per share for the current fiscal year.
In other Tenet Healthcare news, Director Ashish Dave sold 75,000 shares of the business’s stock in a transaction dated Friday, March 9th. The stock was sold at an average price of $1.40, for a total value of $105,000.00. 1.20% of the stock is currently owned by insiders.
About Tenet Healthcare
Tenet Healthcare Corporation operates as a diversified healthcare services company. It operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The company's general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.